Inspire Medical Systems' stock plummeted 5.66% during intraday trading on Monday, following the release of its first quarter 2026 financial results.
The company reported a quarterly loss per share of USD -0.39 and a net loss of USD -11.3 million. Revenue growth for the quarter was a modest 1.6%.
Inspire Medical Systems also updated its full-year 2026 guidance alongside these results, which appears to have contributed to negative investor sentiment and the sharp decline in share price.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.